281 related articles for article (PubMed ID: 14622396)
1. Tinea capitis due to Microsporum audouinii in Malta.
Vella Zahra L; Vella Briffa D
Mycoses; 2003; 46(9-10):433-5. PubMed ID: 14622396
[TBL] [Abstract][Full Text] [Related]
2. Exploring treatment and antifungal resistance in an outbreak of tinea caused by Microsporum audouinii.
Johansen CD; Shen JJR; Astvad KMT; Jemec GBE; Christensen JJ; Saunte DML
Mycoses; 2024 Jul; 67(7):e13760. PubMed ID: 38943042
[TBL] [Abstract][Full Text] [Related]
3. Tinea capitis caused by Microsporum canis treated with terbinafine.
Aste N; Pau M
Mycoses; 2004 Oct; 47(9-10):428-30. PubMed ID: 15504128
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
[TBL] [Abstract][Full Text] [Related]
5. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R
Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791
[TBL] [Abstract][Full Text] [Related]
6. Tinea Capitis by Microsporum audouinii: Case Reports and Review of Published Global Literature 2000-2016.
Brito-Santos F; Figueiredo-Carvalho MHG; Coelho RA; Sales A; Almeida-Paes R
Mycopathologia; 2017 Dec; 182(11-12):1053-1060. PubMed ID: 28736794
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of terbinafine in the treatment of three children with tinea tonsurans.
Desgarennes MD; Godoy MR; Palencia AB
J Am Acad Dermatol; 1996 Jul; 35(1):114-6. PubMed ID: 8682948
[No Abstract] [Full Text] [Related]
8. Microsporum audouinii: Re-Emergence of Ringworm Due to the Dermatophyte.
Lozano-Masdemont B; Carrasco-Fernández B; Polimón-Olabarrieta I; Durán-Valle MT
Actas Dermosifiliogr (Engl Ed); 2019 Nov; 110(9):785-787. PubMed ID: 31153545
[No Abstract] [Full Text] [Related]
9. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
[TBL] [Abstract][Full Text] [Related]
10. Continuous increase of Trichophyton tonsurans as a cause of tinea capitis in the urban area of Paris, France: a 5-year-long study.
Gits-Muselli M; Benderdouche M; Hamane S; Mingui A; Feuilhade de Chauvin M; Guigue N; Picat MQ; Bourrat E; Petit A; Bagot M; Alanio A; Bretagne S
Med Mycol; 2017 Jul; 55(5):476-484. PubMed ID: 27744309
[TBL] [Abstract][Full Text] [Related]
11. Tinea capitis.
Gupta AK; Summerbell RC
Med Mycol; 2000 Aug; 38(4):255-87. PubMed ID: 10975696
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
Ghannoum MA; Wraith LA; Cai B; Nyirady J; Isham N
Br J Dermatol; 2008 Sep; 159(3):711-3. PubMed ID: 18510668
[TBL] [Abstract][Full Text] [Related]
13. Oral terbinafine for tinea capitis due to Microsporum canis in children.
Baleviciene G; Ceburkovas O; Maciuliene D
Acta Derm Venereol; 2001; 81(1):61. PubMed ID: 11411922
[No Abstract] [Full Text] [Related]
14. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.
Fuller LC; Smith CH; Cerio R; Marsden RA; Midgley G; Beard AL; Higgins EM; Hay RJ
Br J Dermatol; 2001 Feb; 144(2):321-7. PubMed ID: 11251566
[TBL] [Abstract][Full Text] [Related]
15. Terbinafine: efficacy and tolerability in young children with tinea capitis due to Microsporum canis.
Silm H; Karelson M
J Eur Acad Dermatol Venereol; 2002 May; 16(3):228-30. PubMed ID: 12195561
[TBL] [Abstract][Full Text] [Related]
16. Tinea capitis in adults.
Aste N; Pau M; Biggio P
Mycoses; 1996; 39(7-8):299-301. PubMed ID: 9009649
[TBL] [Abstract][Full Text] [Related]
17. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.
Cáceres-Ríos H; Rueda M; Ballona R; Bustamante B
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):80-4. PubMed ID: 10607324
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes for tinea capitis in a skin of color population.
Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
[TBL] [Abstract][Full Text] [Related]
20. Microsporum audouinii tinea capitis in a Swiss school: assessment and management of patients and asymptomatic carriers.
Donghi D; Hauser V; Bosshard PP
Med Mycol; 2011 Apr; 49(3):324-8. PubMed ID: 20936914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
